Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 2Recurrence 1Prostatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neurofibromatosis 2 1Meningioma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Glioblastoma 1Estrogen Receptor Positive Breast Cancer 1Disease 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Advanced Solid Malignancies 1Advanced Metastatic Breast Cancer 1Advanced Cancer 1Adenocarcinoma 1

Interventions

vistusertib 1ribociclib 1Tamoxifen 1Letrozole 1Goserelin 1Fulvestrant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Metastatic Breast Cancer × vistusertib × Clear all
NCT01597388 2026-02-24

AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

AstraZeneca

Phase 1 Completed
99 enrolled 61 charts
Breast

Advanced Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡